From the Wires
Aviir CEO Dr. Douglas Harrington To Present The Facts Concerning Heart Disease At The "Head to Toe" Women's Expo In Del Mar On November 10
Heart disease, the leading killer of women in the U.S., is also a major cause of disability and bankruptcy, according to Dr. Harrington
By: PR Newswire
Nov. 9, 2012 01:59 AM
IRVINE, Calif., Nov. 9, 2012 /PRNewswire/ -- Dr. Douglas Harrington, CEO of Aviir Inc., leads an inspiring presentation at the Head to Toe Women's Expo on Saturday, November 10 at the Del Mar Fairgrounds to discuss America's leading threat to women: Heart Disease. Dr. Harrington's lecture "Everything You Ever Wanted to Know About Heart Disease But Were Afraid to Ask" provides a deeper insight into the disease and how women can empower themselves to improve their cardiovascular health. The presentation will began at 12 noon on the Style Stage.
As CEO of Aviir, Dr. Harrington brings more than 25 years of experience in the discovery and creation of unique laboratory tests to guide clinical decisions. Aviir is an Irvine-based biotechnology company, specializing in the development of innovative tests which are designed to give individuals personalized information to influence a preventative lifestyle. Dr. Harrington's mission is to use this information to encourage individuals to take responsibility for their own heart health.
GUARDaHEART Foundation will contract with Aviir to sponsor on-site heart risk assessments at the event. Since 1 out of every 3 individuals in the US has some form of heart disease, GUARDaHEART has launched the "Save The 1" movement. Designed to raise awareness for heart disease, this movement encourages individuals to consult their physician and learn more about their cardiac risk. With knowledge comes power to make critical lifestyle modifications that inspire life.
"Heart Disease remains the leading cause of death in the US, claiming almost 600,000 lives each year, yet many are unaware that 80% of heart disease is preventable through lifestyle modification," said Dr. Harrington. An innovative blood test will also be presented at the event, developed by Aviir through a Stanford University cardiology collaboration, which identifies an individuals' cardiac risk in a five-year timeframe. "This timeframe allows preventive measures to be implemented," continued Dr. Harrington. "Our mission is to improve healthcare and encourage timely preventive strategies by providing this unique medical information."
About Aviir, Inc.
ABOUT THE HEAD TO TOE WOMEN'S EXPO
For media inquiries, please contact:
SOURCE Aviir, Inc.
Latest Cloud Developer Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week